Form 8-K - Current report:
SEC Accession No. 0000950123-09-010622
Filing Date
2009-06-03
Accepted
2009-06-02 18:59:07
Documents
4
Period of Report
2009-05-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c86406e8vk.htm 8-K 9752
2 EXHIBIT 99.1 c86406exv99w1.htm EX-99.1 20915
3 EXHIBIT 99.2 c86406exv99w2.htm EX-99.2 13791
4 GRAPHIC c86406p8640601.gif GRAPHIC 3273
  Complete submission text file 0000950123-09-010622.txt   50719
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 09869520
SIC: 2835 In Vitro & In Vivo Diagnostic Substances